Image source: Getty Images

Experts are calling this the biggest success in the treatment of pancreatic cancer in decades. It's a pill taken daily that appears to help shrink, and possibly eliminate, tumors in some patients with this deadly and difficult-to-treat cancer.

In early medical trials, one in every 12 patients taking daraxonrasib along with chemotherapy had no cancer detected in their scans.

Of the 61 patients included in the trial, almost all tumors stopped growing. These patients were recently diagnosed with advanced pancreatic cancer, which had spread to other parts of the body.

However, doctors say that it is not yet clear how long the medicine can keep the disease under control. It should not be considered a cure or a complete cure for cancer.

End

'The biggest progress in decades'

Image source: Dr Michael May/Dr Wungki Park/Memorial Sloan Kettering Cancer Center/Press Association

Cancer Research UK has described this as 'the biggest advance in decades' for pancreatic cancer patients.

The institute's doctor Sam Godfrey told BBC News that these results are very encouraging.

He said, "This new medicine has found a way to control with medicine that thing which till now was not considered possible to be controlled with medicine."

He said, "We are finally seeing progress in the treatment of pancreatic cancer that has been needed for a long time."

Treatment of pancreatic cancer is considered very difficult. It has the lowest survival rate of all the common cancers in the UK.

Chemotherapy can reduce the size of the tumor to some extent, but often the cancer starts growing again.

Most patients suffering from advanced cancer survive only for a few months, not for years.

Doctors hope the new treatment may give patients more time, even if it may not eliminate the cancer forever.

In this trial, patients were monitored for an average of one and a half years. During this period, cancer did not return in some patients.

Longer-term studies are needed to understand whether the cancer in these patients can go into remission and how long this condition can last.

During this period, the results of the first and second phase of testing were as follows-

Hope for long life

Special stories selected for you by Nitin Srivastava

Learn more

Dr. Woongki Park of America's Memorial Sloan Kettering Cancer Center is also associated with this trial. He said that the results so far are very encouraging.

He said, "Not only are we seeing an increase in the proportion of patients responding to tumor treatment, but the effectiveness of treatment is much greater than before. The period of keeping the disease under control has also almost doubled. This may increase the chances of patients surviving longer in the future."

Daraxonrasib is a targeted inhibitor drug, which has already been approved in the US. It affects certain mutations called RAS and prevents them from becoming active.

These mutations are mostly found in pancreatic cancer and cause tumor growth.

Similar mutations can be found in many other types of cancer including lung and ovarian cancer. In such a situation, this medicine can be helpful for other cancer patients also.

Dr. Godfrey said, "I hope that the initial success we are seeing in pancreatic cancer can be used in the treatment of other cancers as well."

He said that long-term tests and their results are extremely important.

He said, "Cancer can come back again. No signs of it being seen in the scan does not mean that you are completely cancer free. For this more time has to pass."

How serious is pancreatic cancer?

Professor Elena Geralda, chair of the EORTC-NCI-AACR Symposium 2026, a cancer conference in Europe, said: "These results are encouraging, because they show that using both treatments together can extend the overall survival of patients. It can also increase the time until the tumor grows back."

This research is being presented to the doctors in this conference.

Pancreatic cancer accounts for about 3 percent of the total cancer cases in America. At the same time, about 8 percent of the total deaths due to cancer are due to this disease. Every year about 53,000 people die due to this disease.

According to Cancer Research UK, about 11,500 cases of pancreatic cancer are reported every year in Britain and about 10,200 people die from it.

Actor Alan Rickman also died of the same disease in 2016. He died five months after the disease was diagnosed.

Symptoms of pancreatic cancer may include jaundice, skin itching, dark urine, light stool, unexplained weight loss, fatigue and high fever.

We used AI to translate this article, which was originally written in English. A BBC journalist checked this translation before publication. Learn more about how we're using AI.

Published by Collective Newsroom for the BBC.

Download the new BBC World Service app

Choose BBC News Hindi and get news alerts, live TV, podcasts... all in one place

Please note: The new app is not available in the UK and US.

short video

end of short video

top story

Nepal PM Balen Shah's first visit to India, is this a new beginning of friendship?

Live, what did Donald Trump say about India's GDP now?

Indian citizen Nikhil Gupta sentenced to 19 years imprisonment in the case of conspiracy to murder Gurpatwant Singh Pannu in America.

must read

most popular